2m 2m 2m 2m 2m 2m 2m
BIOTE-A (BTMD)
NASDAQ
$2.30+$0.010 (+0.44%)
Price as of Aug 04, 2026 10:12 AM EDT- $69.5MMarket Cap
- -44.55%1-Year Change
- Medical Care FacilitiesIndustry
BIOTE-A (BTMD)
$2.30+$0.010 (+0.44%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 186.9M -5.21% | 197.2M +6.38% | 185.4M +12.37% | 165.0M N/A | |
Cost of Revenue | 51.1M -12.01% | 58.1M +0.44% | 57.9M +6.05% | 54.6M N/A | |
Gross Profit | 135.8M -2.36% | 139.1M +9.08% | 127.5M +15.49% | 110.4M N/A | |
Sales and Marketing Expense | 101.8M -5.25% | 107.5M +8.73% | 98.8M +2,035.39% | 4.6M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 3.7M +2.69% | 3.6M +19.37% | 3.0M +36.15% | 2.2M N/A | |
Total Operating Expenses | 101.8M -5.25% | 107.5M +8.73% | 98.8M -40.29% | 165.5M N/A | |
Operating Profit | 35.6M +12.46% | 31.6M +10.31% | 28.7M +147.19% | -60.7M +1,728.04% | |
Interest Income | 900,000 -55.00% | 2.0M N/A | N/A N/A | 1.1M N/A | |
Interest Expense | -11.0M -0.36% | -11.0M +72.89% | -6.4M +24.99% | -5.1M N/A | |
Interest Income and Expense and Net | -10.1M +11.78% | -9.0M +41.46% | -6.4M +58.36% | -4.0M N/A | |
Total Nonoperating Income and Expense | 2.0M +106.64% | -30.6M +6.31% | -28.8M -146.10% | 62.4M N/A | |
Income before Taxes | 37.6M +3,599.21% | 1.0M +926.02% | -123,000 -107.18% | 1.7M +151.54% | |
Income Taxes | 6.0M +517.22% | 970,000 -63.83% | 2.7M +591.24% | 388,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 27.0M +756.67% | 3.2M -4.79% | 3.3M +442.21% | -969,000 -108.72% | |
Net Income from Continuing Operations Applicable to Common | 37.6M +3,599.21% | 1.0M +926.02% | -123,000 -107.18% | 1.7M -84.59% | |
Basic EPS and Net Income | 0.86 +855.56% | 0.09 -30.77% | 0.13 +208.33% | -0.12 -118.18% | |
Diluted EPS and Net Income | 0.74 +722.22% | 0.09 -30.77% | 0.13 +208.33% | -0.12 -118.75% | |
Basic Weighted Average Shares | 31.3M -8.72% | 34.3M +33.30% | 25.7M +219.00% | 8.1M -76.38% | |
Diluted Weighted Average Shares | 36.7M +6.99% | 34.3M +33.30% | 25.7M +219.00% | 8.1M -76.52% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 24.1M -38.68% | 39.3M -55.80% | 89.0M +12.33% | 79.2M +60,679.08% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 24.1M -38.68% | 39.3M -55.80% | 89.0M +12.33% | 79.2M +60,679.08% | |
Total Current Assets | 54.7M -19.75% | 68.1M -44.31% | 122.3M +20.92% | 101.2M +22,303.45% | |
Accumulated Depreciation | 7.6M +19.28% | 6.4M +14.09% | 5.6M +16.72% | 4.8M N/A | |
Property and Plant and Equipment and Net | 10.8M +54.21% | 7.0M +472.50% | 1.2M -19.02% | 1.5M N/A | |
Total Long-Term Assets | 72,000 0.00% | 72,000 -94.09% | 1.2M -19.02% | 1.5M -99.53% | |
Total Assets | 107.6M -12.06% | 122.4M -21.20% | 155.3M +39.10% | 111.6M -64.90% | |
Income Taxes Payable | N/A N/A | 17,000 0.00% | 17,000 N/A | N/A N/A | |
Total Short-Term Debt | 6.3M 0.00% | 6.3M 0.00% | 6.3M 0.00% | 6.3M N/A | |
Total Current Liabilities | 45.0M -12.66% | 51.5M +131.89% | 22.2M +18.38% | 18.8M +725.90% | |
Total Long-Term Debt | 100.8M -0.41% | 101.2M -5.09% | 106.6M -4.87% | 112.1M N/A | |
Total Long-Term Liabilities | 344,000 -77.07% | 1.5M -99.03% | 154.8M +2.44% | 151.2M +623.53% | |
Total Liabilities | 158.0M -29.64% | 224.6M +17.06% | 191.8M +12.90% | 169.9M +633.57% | |
Retained Earnings | -49.5M -50.60% | -100.3M +241.25% | -29.4M -33.89% | -44.5M +96.46% | |
Total Stockholders Equity | -58.5M -44.74% | -105.9M +260.34% | -29.4M -33.88% | -44.5M +96.46% | |
Total Shares Outstanding | 30.7M -16.33% | 36.7M -41.80% | 63.1M +8.34% | 58.2M +633.50% | |
Cash Flow | |||||
Cash from Operating Activities | 35.2M -22.21% | 45.2M +68.30% | 26.9M +393.58% | -9.2M +568.02% | |
Capital Expenditures | 5.0M -22.01% | 6.4M +1,691.09% | 359,000 +7.81% | 333,000 N/A | |
Cash from Investing Activities | -6.9M -63.49% | -18.8M +592.89% | -2.7M +47.61% | -1.8M -99.42% | |
Dividends Paid | 1.7M -63.60% | 4.7M -45.43% | 8.7M -32.53% | 12.9M N/A | |
Cash from Financing Activities | -43.6M -42.75% | -76.1M +429.09% | -14.4M -122.66% | 63.5M -80.11% | |
Financials Ratio | |||||
Gross Margin | 72.64% +3.00% | 70.52% +2.54% | 68.78% +2.78% | 66.92% N/A | |
Operating Margin | 19.02% +18.64% | 16.03% +3.69% | 15.46% +142.00% | -36.81% N/A | |
Return on Assets | 23.52% +934.26% | 2.27% -8.47% | 2.48% +650.89% | -0.45% N/A | |
Return on Equity | -32.89% +604.88% | -4.67% -48.04% | -8.98% -410.85% | 2.89% N/A | |
Revenue Growth | -5.21% -181.57% | 6.38% -48.40% | 12.37% N/A | N/A N/A | |
Current Ratio | 1.22 -8.12% | 1.32 -75.99% | 5.51 +2.14% | 5.39 N/A | |
Cash Ratio | 0.54 -29.79% | 0.76 -80.94% | 4.01 -5.11% | 4.22 N/A | |
Debt-to-Equity Ratio | -1.83 +80.24% | -1.01 -73.58% | -3.84 +44.26% | -2.66 N/A | |
Debt-to-Assets Ratio | 0.99 +13.27% | 0.88 +20.80% | 0.73 -31.42% | 1.06 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow